kl-7shrna
Nucleic acidexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 5, 2023 (NCT05922384)
Timeline
No events for the selected filters.
Mechanism of action
- Human immunodeficiency virusANTISENSE INHIBITOR
Human immunodeficiency virus antisense inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05922384 | N/A | Jul 5, 2023 | Guangdong Medical University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Guangdong Medical University | Academic/Hospital | 1 | 1 | 1 | 2023 |
1 organizations
Page 1 / 1